The Centre for the Development of Industrial Technology (CDTI) has approved a project (1.224.488,00 euros) submitted by INMUNOTEK SL for the pharmaceutical development of a new conjugated vaccine.

This project has the collaboration of the Complutense University of Madrid (Faculty of Chemistry and Medicine), and the Spanish National Research Council (CSIC) and includes toxicological and dose-finding studies with the collaboration of different hospitals from Madrid and Valencia (Spain).  The CDTI is a Public Business Entity, answering to the Ministry of Economy and Competitiveness, which fosters the technological development and innovation of Spanish companies.